Abstract
The purpose of this prospective randomized open trial was to investigate the impact of monitoring concentrations in serum on the efficacy and side effects of high-dose co-trimoxazole therapy. Forty consecutive patients with microscopically confirmed Pneumocystis carinii pneumonia were enrolled. Therapy was started with 5 and 25 mg of trimethoprim and sulfamethoxazole, respectively, per kg of body weight given every 6 h for 2 days and continued every 8 h either with (group A) or without (group B) monitoring and dose adjustments according to sulfamethoxazole levels in serum (target, 150 to 200 micrograms/ml) for a total of 21 days. Only 7 of 19 patients (83%). Patients who were treated for the full period and patients for whom co-trimoxazole was prematurely stopped had similar concentrations of sulfamethoxazole (157 +/- 52 versus 155 +/- 47 micrograms/ml) and trimethoprim (5.0 +/- 1.4 versus 5.6 +/- 1.0 microgram/ml). Concentrations of sulfamethoxazole and trimethoprim in group A (158 +/- 39 and 5.6 +/- 1.8 micrograms/ml, respectively) did not differ from those in group B (153 +/- 57 and 5.1 +/- 1.6 micrograms/ml, respectively), and the average daily maintenance doses for groups A (75.4 mg/kg plus 15.1 mg/kg) and B (76.4 mg/kg pl...Continue Reading
References
Aug 17, 1991·Lancet·A J van der VenJ W van der Meer
Jan 1, 1991·Clinical Pharmacology and Therapeutics·M J RiederS P Spielberg
Apr 12, 1986·Lancet·F J BowdenC R Lucas
Feb 15, 1989·Annals of Internal Medicine·M J RiederS P Spielberg
Aug 15, 1988·Annals of Internal Medicine·F R SattlerJ Ruskin
Jul 1, 1986·Annals of Internal Medicine·J M WhartonP C Hopewell
Nov 12, 1983·Lancet·H S JaffeJ A Golden
Jan 1, 1995·Antimicrobial Agents and Chemotherapy·T W ChinI W Fong
Mar 1, 1995·AIDS·P P KoopmansJ W van der Meer
Mar 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M OpravilG Praz
Feb 1, 1995·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·M J RiederG A Dekaban
Mar 1, 1994·AIDS·A CarrD A Cooper
Jul 1, 1993·Infection·J BlaserR Lüthy
Jan 1, 1993·The Journal of Infectious Diseases·A CarrD A Cooper
May 27, 1993·The New England Journal of Medicine·W HughesC Chan
May 1, 1993·Clinical Pharmacokinetics·H F Vöhringer, K Arastéh
Citations
Feb 3, 2009·Transactions of the Royal Society of Tropical Medicine and Hygiene·J LindkvistY Bergqvist
Feb 4, 1998·Critical Care Clinics·C F Decker, H Masur
Oct 24, 1998·Journal of Clinical Pharmacy and Therapeutics·H KlinkerE Richter
May 25, 2013·Science·Hirohito HarukiKai Johnsson
May 23, 2002·Antimicrobial Agents and Chemotherapy·Javier AfeltraUNKNOWN Eurofung Network
May 3, 2005·Biological & Pharmaceutical Bulletin·Shunsuke HidaNaohito Ohno
Mar 2, 2013·PloS One·Christine ManyandoJean-Pierre Van Geertruyden
Oct 15, 2013·The Journal of Antimicrobial Chemotherapy·Sirwan Muhammed AmeenMichel Drancourt
Sep 14, 2000·Proceedings of the National Academy of Sciences of the United States of America·F SestiS A Goldstein
Aug 30, 2014·Infection·P NickelD Schürmann
Nov 20, 2009·Scandinavian Journal of Infectious Diseases·Mark ThomasRod Ellis-Pegler
Nov 20, 2014·Current Therapeutic Research, Clinical and Experimental·Bao D DaoPritish K Tosh
Aug 26, 2010·Therapeutic Advances in Respiratory Disease·Eva M Carmona, Andrew H Limper
Aug 12, 2017·British Journal of Clinical Pharmacology·Claire PressiatUNKNOWN MONOD Study Group
Aug 8, 2017·Expert Review of Anti-infective Therapy·Yu-Shan HuangChien-Ching Hung
Oct 18, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ki-Ho ParkFederico Sesti
Nov 1, 2017·Antimicrobial Agents and Chemotherapy·Julie AutmizguineUNKNOWN the Pediatric Trials Network Steering Committee
Jun 13, 1998·Antimicrobial Agents and Chemotherapy·J A Fishman
Feb 3, 2016·Therapeutic Drug Monitoring·Lauren L IcePritish K Tosh
Feb 5, 2021·Clinical Pharmacology and Therapeutics·Kevin J Downes, Jennifer L Goldman
Nov 8, 2020·Clinica Chimica Acta; International Journal of Clinical Chemistry·Sophia Rehm, Katharina M Rentsch
Apr 28, 2021·Antimicrobial Agents and Chemotherapy·Yi Shuan S WuUNKNOWN Best Pharmaceuticals for Children Act—Pediatric Trials Network Steering Committee